Management of Common Neurologic Symptoms in Pediatric Palliative Care: Seizures, Agitation, and Spasticity

Pediatric Clinics of North America

Volumn 54, Issue 5, 2007, Pages 709-733

  Wusthoff, Courtney J ^a   Shellhaas, Renée A ^a   Licht, Daniel J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGITATION; CHILD; CHILD CARE; CHILDHOOD DISEASE; HUMAN; NEUROLOGIC DISEASE; PALLIATIVE THERAPY; REVIEW; SEIZURE; SPASTICITY; SYMPTOM;

BRAIN; CHILD; DRUG THERAPY; HUMANS; MUSCLE SPASTICITY; PALLIATIVE CARE; PSYCHOMOTOR AGITATION; SEIZURES;

EID: 35148813585     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2007.06.004     Document Type: Review

References (55)

1. Himelstein B.P., Hilden J.M., Boldt A.M., et al. Pediatric palliative care. N Engl J Med 350 17 (2004) 1752-1762
2. Hain R.D. Paediatric palliative medicine: a unique challenge. Pediatr Rehabil 7 2 (2004) 79-84
3. Association for Children with Life-threatening or Terminal Conditions and their Families. A guide to the development of children's palliative care services (1997), Royal College of Paediatrics and Child Health, Bristol (London)
4. Paneth N., Hong T., and Korzeniewski S. The descriptive epidemiology of cerebral palsy. Clin Perinatol 33 2 (2006) 251-267
5. van Stuijvenberg M., de Vos S., Tjiang G.C., et al. Parents' fear regarding fever and febrile seizures. Acta Paediatr 88 6 (1999) 618-622
6. Baumer J.H., David T.J., Valentine S.J., et al. Many parents think their child is dying when having a first febrile convulsion. Dev Med Child Neurol 23 4 (1981) 462-464
7. Arunkumar G., Wyllie E., Kotagal P., et al. Parent- and patient-validated content for pediatric epilepsy quality-of-life assessment. Epilepsia 41 11 (2000) 1474-1484
8. Sullivan J., and Dlugos D. Antiepileptic drug monotherapy: pediatric concerns. Seminars in Pediatric Neurology 12 (2005) 88-96
9. French J., and Gidal B. Antiepileptic drug interactions. Epilepsia 41 Suppl 8 (2000) S30-S36
10. Perucca E., Dulac O., Shorvon S., et al. Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation. CNS Drugs 15 8 (2001) 609-621
11. Levy R.H., Mattson R.H., Meldrum B.S., et al. Antiepileptic drugs. 5th edition (2002), Lippincott Williams & Wilkins, Philadelphia
12. Sander J. The use of antiepileptic drugs-principles and practice. Epilepsia 45 Suppl 6 (2004) 28-34
13. O'Dell C., Shinnar S., Ballaban-Gil K.R., et al. Rectal diazepam gel in the home management of seizures in children. Pediatr Neurol 33 3 (2005) 166-172
14. McIntyre J., Robertson S., Norris E., et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 366 9481 (2005) 205-210
15. Pellock J.M., and Shinnar S. Respiratory adverse events associated with diazepam rectal gel. Neurology 64 10 (2005) 1768-1770
16. Cloyd J.C., Lalonde R.L., Beniak T.E., et al. A single-blind, crossover comparison of the pharmacokinetics and cognitive effects of a new diazepam rectal gel with intravenous diazepam. Epilepsia 39 5 (1998) 520-526
17. Cummings M.R., and Miller B.D. Pharmacologic management of behavioral instability in medically ill pediatric patients. Curr Opin Pediatr 16 5 (2004) 516-522
18. Houlahan K.E., Branowicki P.A., Mack J.W., et al. Can end of life care for the pediatric patient suffering with escalating and intractable symptoms be improved?. J Pediatr Oncol Nurs 23 1 (2006) 45-51
19. Kehl K.A. Treatment of terminal restlessness: a review of the evidence. J Pain Palliat Care Pharmacother 18 1 (2004) 5-30
20. Travis S.S., Conway J., Daly M., et al. Terminal restlessness in the nursing facility: assessment, palliation, and symptom management. Geriatr Nurs 22 6 (2001) 308-312
21. Turkel S.B., Trzepacz P.T., and Tavare C.J. Comparing symptoms of delirium in adults and children. Psychosomatics 47 4 (2006) 320-324
22. Gattera J.A., Charles B.G., Williams G.M., et al. A retrospective study of risk factors of akathisia in terminally ill patients. J Pain Symptom Manage 9 7 (1994) 454-461
23. Thwaites D., McCann S., and Broderick P. Hydromorphone neuroexcitation. J Palliat Med 7 4 (2004) 545-550
24. Drake R., Frost J., and Collins J.J. The symptoms of dying children. J Pain Symptom Manage 26 1 (2003) 594-603
25. Bottomley D.M., and Hanks G.W. Subcutaneous midazolam infusion in palliative care. J Pain Symptom Manage 5 4 (1990) 259-261
26. Henderson M., MacGregor E., Sykes N., et al. The use of benzodiazepines in palliative care. Palliat Med 20 4 (2006) 407-412
27. Burke A.L., Diamond P.L., Hulbert J., et al. Terminal restlessness-its management and the role of midazolam. Med J Aust 155 7 (1991) 485-487
28. Weisman S.J. Supportive care in children with cancer. In: Berger A., Portenoy R.K., and Weissman D.E. (Eds). Principles and practice of supportive oncology (1998), Lippincott-Raven, Philadelphia 845-851
29. Harrison A.M., Lugo R.A., Lee W.E., et al. The use of haloperidol in agitated critically ill children. Clin Pediatr (Phila) 41 1 (2002) 51-54
30. McIver B., Walsh D., and Nelson K. The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 9 5 (1994) 341-345
31. Fugate L.P., Spacek L.A., Kresty L.A., et al. Measurement and treatment of agitation following traumatic brain injury: II. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation. Arch Phys Med Rehabil 78 9 (1997) 924-928
32. Fleminger S. Greenwood RJ, Oliver DL. Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst Rev 4 (2006) CD003299
33. Stirling L.C., Kurowska A., and Tookman A. The use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage 17 5 (1999) 363-368
34. Collins J.J. Paediatric palliative medicine: symptom control in life-threatening illness. In: Doyle D. (Ed). Oxford textbook of palliative medicine. 3rd edition (2004), Oxford University Press, Oxford (UK) 789-798
35. Hicks F., and Pearse H. Palliative care for people with progressive neurological disorders. In: Faull C., Carter Y., and Daniels L. (Eds). Handbook of palliative care. 2nd edition (2005), Blackwell Pub., Malden (MA) 256-272
36. Good P.D., Cavenagh J.D., Currow D.C., et al. What are the essential medications in pallative care?-A survey of Australian palliative care doctors. Aust Fam Physician 35 4 (2006) 261-264
37. Krauss B. Management of acute pain and anxiety in children undergoing procedures in the emergency department. Pediatr Emerg Care 17 2 (2001) 115-122
38. Kang T., Hoehn K.S., Licht D.J., et al. Pediatric palliative, end-of-life, and bereavement care. Pediatr Clin North Am 52 4 (2005) 1029-1046 viii
39. Friebert S., and Hilden J.M. Palliative care. In: Altman A.J., and Children's Oncology Group (Eds). Supportive care of children with cancer: current therapy and guidelines from the children's oncology group. 3rd edition (2004), Johns Hopkins University Press, Baltimore (MD) 379-396
40. Tremblay A., and Breitbart W. Psychiatric dimensions of palliative care. Neurol Clin 19 4 (2001) 949-967
41. Nauck F., Ostgathe C., Klaschik E., et al. Drugs in palliative care: results from a representative survey in Germany. Palliat Med 18 2 (2004) 100-107
42. Miser J., and Miser A. Pain and symptom control. In: Armstrong-Dailey A., and Goltzer S.Z. (Eds). Hospice care for children (1993), Oxford University Press, New York 22-59
43. Mysiw W.J., and Sandel M.E. The agitated brain injured patient. Part 2: pathophysiology and treatment. Arch Phys Med Rehabil 78 2 (1997) 213-220
44. Shapiro B.A., Warren J., Egol A.B., et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med 23 9 (1995) 1596-1600
45. Hooke M.C., Grund E., Quammen H., et al. Propofol use in pediatric patients with severe cancer pain at the end of life. J Pediatr Oncol Nurs 24 1 (2007) 29-34
46. Verrotti A., Greco R., Spalice A., et al. Pharmacotherapy of spasticity in children with cerebral palsy. Pediatr Neurol 34 1 (2006) 1-6
47. Himelstein B.P. Palliative care for infants, children, adolescents, and their families. J Palliat Med 9 1 (2006) 163-181
48. Pin T., Dyke P., and Chan M. The effectiveness of passive stretching in children with cerebral palsy. Dev Med Child Neurol 48 10 (2006) 855-862
49. Sibson K., Craig F., and Goldman A. Palliative care for children. In: Faull C., Carter Y., and Daniels L. (Eds). Handbook of palliative care. 2nd edition (2005), Blackwell Pub., Malden (MA) 295-316
50. Kurent J.E. Neurological diseases. In: Taylor G.J., and Kurent J.E. (Eds). A clinician's guide to palliative care (2003), Blackwell Pub., Malden (MA) 104-127
51. Chou R., Peterson K., and Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 28 2 (2004) 140-175
52. Smith H.S., and Barton A.E. Tizanidine in the management of spasticity and musculoskeletal complaints in the palliative care population. Am J Hosp Palliat Care 17 1 (2000) 50-58
53. Lubsch L., Habersang R., Haase M., et al. Oral baclofen and clonidine for treatment of spasticity in children. J Child Neurol 21 12 (2006) 1090-1092
54. Berweck S., and Heinen F. Use of botulinum toxin in pediatric spasticity (cerebral palsy). Mov Disord 19 Suppl 8 (2004) S162-S167
55. Heinen F., Molenaers G., Fairhurst C., et al. European consensus table 2006 on botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 10 5-6 (2006) 215-225